跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“Hao1”
全部
20
临床试验
8
药物
5
机构
0
资讯
7
2年前
FDA Clears IND for Arbor Biotechnologies' ABO-101 Gene-Editing Therapy for Primary Hyperoxaluria Type 1
去年
YolTech's YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 with Positive Clinical Data
2个月前
ABO-101 Gene Editing Therapy for Primary Hyperoxaluria Type 1 Granted Orphan Drug Designation by European Commission
10个月前
YolTech Therapeutics Receives FDA Clearance for First Pivotal Trial of In Vivo Gene-Editing Therapy for Primary Hyperoxaluria Type 1
去年
Arbor Biotechnologies' ABO-101 Receives FDA Clearance for Phase 1/2 Trial in Primary Hyperoxaluria Type 1
7个月前
RNA Interference Therapy Market Expands with 90+ Drugs in Development Across 40+ Companies
3个月前
UConn Health Researcher Awarded $20,000 Grant to Study Molecular Basis of Hao-Fountain Syndrome